13.78
Schlusskurs vom Vortag:
$13.73
Offen:
$13.91
24-Stunden-Volumen:
189.18K
Relative Volume:
0.28
Marktkapitalisierung:
$3.76B
Einnahmen:
$1.35B
Nettoeinkommen (Verlust:
$159.12M
KGV:
23.63
EPS:
0.5831
Netto-Cashflow:
$12.86M
1W Leistung:
+2.56%
1M Leistung:
-10.35%
6M Leistung:
-43.68%
1J Leistung:
-27.37%
Stevanato Group Spa Stock (STVN) Company Profile
Compare STVN vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
STVN
Stevanato Group Spa
|
13.78 | 3.75B | 1.35B | 159.12M | 12.86M | 0.5831 |
|
ISRG
Intuitive Surgical Inc
|
451.71 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
154.99 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
74.52 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.87 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
224.10 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-04-22 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-11-01 | Herabstufung | Jefferies | Buy → Hold |
| 2023-09-26 | Eingeleitet | Stephens | Overweight |
| 2023-09-19 | Eingeleitet | CJS Securities | Market Outperform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-10 | Eingeleitet | BofA Securities | Buy |
| 2021-08-10 | Eingeleitet | Citigroup | Buy |
| 2021-08-10 | Eingeleitet | Jefferies | Buy |
| 2021-08-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-08-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-10 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Stevanato Group Spa Aktie (STVN) Neueste Nachrichten
STVN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stevanato Group S.p.A (NYSE:STVN) Q4 2025 earnings call transcript - MSN
Stevanato Group S.P.A. Provides Earnings Guidance for the Fiscal 2026 - marketscreener.com
Stevanato Q4 2025 slides: HVS drives beat, stock surges 13% - investing.com
STVN Earnings History & Surprises | EPS & Revenue Results | STEVANATO GROUP SPA (NYSE:STVN) - ChartMill
Discipline and Rules-Based Execution in STVN Response - news.stocktradersdaily.com
Stevanato Group’s (STVN) Core Business Improved Despite a 22% Pull Back in Q4 - Yahoo Finance
STVN Technical Analysis & Stock Price Forecast - Intellectia AI
STVN SEC FilingsStevanato Group S P A 10-K, 10-Q, 8-K Forms - Stock Titan
Options Flow: Will Stevanato Group SpA benefit from sector rotationM&A Rumor & Verified Short-Term Trading Plans - baoquankhu1.vn
Stevanato Group S.p.A. $STVN Stock Position Raised by Cooper Investors PTY Ltd. - MarketBeat
Top Stevanato Group (STVN) Competitors 2026 - MarketBeat
Stevanato Group (NYSE:STVN) Reaches New 1-Year LowWhat's Next? - MarketBeat
Director Luciano Santel lists 1,787 Stevanato Group (STVN) shares held - Stock Titan
Stevanato Group (STVN) director Elisabetta Magistretti submits initial Form 3 - Stock Titan
Profit Recap: Is Stevanato Group SpA stock a value trap2026 Analyst Calls & Fast Gain Swing Alerts - baoquankhu1.vn
Fill Finish Manufacturing Market to See Booming Growth 2026-2033 | Stevanato Group, OPTIMA, SGD Pharma - openPR.com
Returns Recap: What are analysts price targets for Stevanato Group SpA2026 Technical Patterns & Expert Verified Movement Alerts - baoquankhu1.vn
Stevanato Group S.P.A. (IT0005452658.SG) Stock Earnings Call Transcripts - finance.yahoo.com
Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales - MSN
Behavioral Patterns of STVN and Institutional Flows - Stock Traders Daily
STVN PE Ratio & Valuation, Is STVN Overvalued - Intellectia AI
[Form 3] Stevanato Group S.p.A. Initial Statement of Beneficial Ownership - Stock Titan
Director Karen Flynn reports Stevanato Group (NYSE: STVN) share stake - Stock Titan
Stevanato Group (STVN) director Federici discloses direct and indirect share holdings - Stock Titan
Director Morel discloses 33,942 Stevanato (STVN) Ordinary Shares in Form 3 - Stock Titan
Stevanato Group (NYSE: STVN) director files Form 3/A with no trades - Stock Titan
Director Lin Sue-Jean discloses 2,000-share stake in Stevanato (STVN) - Stock Titan
Stevanato Group (STVN) director reports holding 65,976 ordinary shares - Stock Titan
Stevanato Group (STVN) CFO discloses ordinary share and multi-year RSU holdings - Stock Titan
Stevanato (NYSE: STVN) director details 253M Class A share holding - Stock Titan
Stevanato Group (STVN) executive discloses 404,942 shares and multiple RSU grants - stocktitan.net
Director Bonanni reports 119,700 Stevanato (NYSE: STVN) shares - Stock Titan
Meme Stocks: Should value investors consider Stevanato Group SpA2026 Final Week & Weekly Hot Stock Watchlists - baoquankhu1.vn
Can Stevanato Group SpA deliver consistent EPS growth2026 Valuation Update & Entry Point Confirmation Signals - baoquankhu1.vn
Stevanato Group S.P.A. (IT0005452658.SG) Stock Price, News, Quote & History - Yahoo Finance
Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN) - Insider Monkey
Fred Alger Management LLC Reduces Stock Position in Stevanato Group S.p.A. $STVN - MarketBeat
Stevanato secures €200M in financing - MSN
Stevanato Group shares jump nearly 17% after strong fourth-quarter results - MSN
Income Plays: Is Stevanato Group SpA a good ESG investmentMarket Trend Report & Accurate Intraday Trade Tips - baoquankhu1.vn
Stevanato Group S.p.A. $STVN Shares Bought by Bamco Inc. NY - MarketBeat
Stevanato Group: Riding The Biologics Boom—Can Its Injectable Solutions Become The Backbone Of Next-Gen Drug Delivery? - Smartkarma
Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Decline in Short Interest - MarketBeat
KeyBanc cuts Stevanato Group stock price target on GLP-1 outlook - Investing.com Nigeria
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum - BioSpace
Stevanato Group Posts 2025 Growth on High-Value Syringes and GLP‑1 Demand - The Globe and Mail
Earnings Miss: Can Stevanato Group SpA keep up with sector leadersWeekly Trend Recap & Expert Verified Movement Alerts - baoquankhu1.vn
[6-K] Stevanato Group S.p.A. Current Report (Foreign Issuer) | STVN SEC FilingForm 6-K - Stock Titan
Finanzdaten der Stevanato Group Spa-Aktie (STVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):